Schonfeld Strategic Advisors’s Diversified Healthcare Trust DHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-619
Closed -$1.46K 1937
2023
Q3
$1.2K Buy
+619
New +$1.57K ﹤0.01% 1669
2023
Q2
Sell
-10,600
Closed -$14.3K 2215
2023
Q1
$14.3K Sell
10,600
-90,242
-89% -$93.3K ﹤0.01% 1851
2022
Q4
$65.2K Buy
+100,842
New +$99.6K ﹤0.01% 2239
2022
Q3
Sell
-26,388
Closed -$48K 3011
2022
Q2
$48K Buy
+26,388
New +$60.3K ﹤0.01% 2228
2021
Q4
Sell
-17,200
Closed -$58K 2227
2021
Q3
$58K Sell
17,200
-9,400
-35% -$35.5K ﹤0.01% 1990
2021
Q2
$112K Buy
26,600
+16,300
+158% +$67.3K ﹤0.01% 1785
2021
Q1
$50K Sell
10,300
-3,700
-26% -$17K ﹤0.01% 1718
2020
Q4
$57K Buy
14,000
+2,200
+19% +$8.67K ﹤0.01% 1490
2020
Q3
$42K Sell
11,800
-27,377
-70% -$107K ﹤0.01% 1307
2020
Q2
$174K Buy
+39,177
New +$138K ﹤0.01% 1128
2018
Q3
Sell
-41,236
Closed -$746K 838
2018
Q2
$746K Buy
+41,236
New +$682K 0.04% 453

Other funds holding DHC

Schonfeld Strategic Advisors's DHC Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of Diversified Healthcare Trust (DHC) in Q4 2023, closing a stake of 619 shares — an estimated $1.46K sold.

Schonfeld Strategic Advisors first reported a position in DHC in Q2 2018 and held it in 11 quarters. The position peaked at $746K in Q2 2018. 179 funds tracked by Wall St. Rank hold DHC as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining Diversified Healthcare Trust position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 619 Diversified Healthcare Trust shares in Q4 2023, an estimated $1.46K.
  • Schonfeld Strategic Advisors first reported a position in Diversified Healthcare Trust in Q2 2018 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's Diversified Healthcare Trust position peaked at $746K in Q2 2018.
  • 179 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.